In vivo and in vitro studies of GAD-antibody positive subjects with Type 2 diabetes: A distinct sub-phenotype
dc.contributor.author | O'Gorman, D. | |
dc.contributor.author | Yousif, O. | |
dc.contributor.author | Dixon, G. | |
dc.contributor.author | McQuaid, S. | |
dc.contributor.author | Murphy, E. | |
dc.contributor.author | Rahman, Y. | |
dc.contributor.author | Gasparro, D. | |
dc.contributor.author | Pacini, G. | |
dc.contributor.author | Newsholme, Philip | |
dc.contributor.author | Nolan, J. | |
dc.date.accessioned | 2017-01-30T12:16:19Z | |
dc.date.available | 2017-01-30T12:16:19Z | |
dc.date.created | 2016-09-12T08:36:25Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | O'Gorman, D. and Yousif, O. and Dixon, G. and McQuaid, S. and Murphy, E. and Rahman, Y. and Gasparro, D. et al. 2008. In vivo and in vitro studies of GAD-antibody positive subjects with Type 2 diabetes: A distinct sub-phenotype. Diabetes Research and Clinical Practice. 80 (3): pp. 365-370. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/19890 | |
dc.identifier.doi | 10.1016/j.diabres.2007.12.009 | |
dc.description.abstract |
The purpose of this study was to determine if immune mechanisms in GAD positive patients' contribute to the pathogenesis of a specific sub-type of Type 2 diabetes. GAD positive (n = 8) and GAD negative (n = 8) subjects diagnosed with Type 2 diabetes were matched for age, gender, body mass index, duration of diabetes and glycaemic control. All subjects underwent an insulin-modified frequently sampled intravenous glucose tolerance test to measure insulin sensitivity and insulin secretory function with minimal model analysis. In addition, BRIN-BD11 clonal ß-cells were supplemented with patients' sera to determine basal and alanine-stimulated insulin secretion and terminal complement complex (TCC) formation. Both groups were severely insulin resistant (0.56 ± 0.17 vs. 0.99 ± 0.33 10-4 min-1/(µU ml-1) for GADneg and GADpos, respectively) but the GAD negative subjects had a higher basal (87 ± 11 vs. 58 ± 14 pmol l-1, p < 0.05) and glucose-stimulated insulin secretion (?AUCins 0.96 ± 0.12 vs. 0.60 ± 0.12 pmol/(l-1 min), p < 0.05). In vivo measures of insulin secretion were negatively correlated with TCC formation, independent of antibody status. In conclusion, GAD positive subjects initially diagnosed with Type 2 diabetes are unable to compensate for insulin resistance due to more pronounced ß-cell impairment. TCC formation may be partly responsible for the insulin secretory dysfunction associated with this specific sub-type of Type 2 diabetes. © 2007 Elsevier Ireland Ltd. All rights reserved. | |
dc.publisher | Elsevier Ireland Ltd | |
dc.title | In vivo and in vitro studies of GAD-antibody positive subjects with Type 2 diabetes: A distinct sub-phenotype | |
dc.type | Journal Article | |
dcterms.source.volume | 80 | |
dcterms.source.number | 3 | |
dcterms.source.startPage | 365 | |
dcterms.source.endPage | 370 | |
dcterms.source.issn | 0168-8227 | |
dcterms.source.title | Diabetes Research and Clinical Practice | |
curtin.department | School of Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |